// App-Quantinova.ai

404 : Autoantibody Profiles Delineate Three Distinct Subsets of Scleromyositis

Researchers

Presenter

  • Valerie Leclair

Principal Investigators

  • Genevieve Gyger

  • Alain Meyer

  • Marvin Fritzler

  • Oceane Landon-Cardinal

  • Erin O'Ferrall

  • Jason Karamchandani

  • Benjamin Ellezam

  • Rami Massie

  • Minoru Satoh

  • Yves Troyanov

  • Marie Hudson

Medical Centers

  • Montreal University, Montreal, QC, Canada

  • Division of Rheumatology, Department of Medicine, Jewish General Hospital; Clinical Epidemiology Unit, Department of Medicine, Karolinska Institutet, Montreal, QC, Canada

  • Division of Nephrology, Department of Medicine, Jewish General Hospital, Montreal, QC, Canada

  • Centre de Reference des Maladies Autoimmunes Rares, Hôpitaux Universitaires de Strasbourg, Strasbourg, France

  • Cumming School of Medicine, University of Calgary, Calgary, AB, Canada

  • Division of Rheumatology, Centre hospitalier de l'Université de Montréal; Department of Medicine, Université de Montréal, Montreal, QC, Canada

  • Montreal Neurological Institute and Hospital, Montreal, Quebec, Canada

  • Centre Hospitalier Universitaire Sainte Justine, Montreal, QC, Canada

  • Department of Clinical Nursing, School of Health Sciences, University of Occupational and Environmental Health, Kitakyushu, Japan

  • Division of Rheumatology, Department of Medicine, Hôpital du Sacre-Coeur de Montreal, Montreal, QC, Canada

  • Jewish General Hospital, Lady Davis Institute for Medical Research, McGill University, Montreal, QC, Canada

Locations

  • Canada

  • France

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

  • Autoimmune (AI)

Disease

  • Scleroderma

  • Myositis

Biomarkers

  • Cluster of differentiation 69

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A